Announcements
Projects
Orgs
Project
Articles 40
Votes 0
OncLive

Authors 41

OncLive Staff
Ryan Scott
Ashling Wahner
Gina Mauro
Silas Inman
Kristi Rosa
Wayne Kuznar
Jason Harris
Josep Tabernero
MD
PhD
Rohit Kumar
Ryan Fecteau
Prateek Gulhati
Megan Kruse
Caroline Seymour
Marisol Miranda-Galvis
DDS
MS
Inderjit Mehmi
Johannes Schetelig
MSc
Joachim G. J. V. Aerts
Toufic A. Kachaamy
Madappa Kundranda
Tamas A. Gonda
Lynn G. Feun
Joshua Hurwitz
Phillip Dennis
Vice President
Lung Cancer
CEACAM Global Project Head
Sanofi
Hemant S. Murthy
University of Miami Health System
Brian Ramnaraign
Komal Jhaveri
FACP
Brett L. Ecker
Kevin Kalinsky
Courtney Flaherty
Dr. Gulhati on Current Treatment Approaches in Pancreatic Cancer - OncLive
almost3y
Checkpoint Inhibitor-Based Salvage Regimens Reduce Post-Transplant Progression in R/R Hodgkin Lymphoma - Targeted Oncology
almost3y
Dr. Fecteau on the Benefit of a Multidisciplinary Approach in Bladder and Prostate Cancers - OncLive
almost3y
TKI/Immunotherapy Combinations Expand RCC Treatment Options - OncLive
almost3y
Dr. Tabernero on the Efficacy of Bevacizumab Plus TAS-102 in Refractory mCRC - OncLive
almost3y
Anti-drug Antibodies Do Not Affect Durvalumab Alone, With Tremelimumab in Unresectable HCC - OncLive
almost3y
Mezigdomide With Dexamethasone Appears Active in Heavily Pretreated Patients With Multiple Myeloma - Targeted Oncology
~3y
Pirtobrutinib Demonstrates High Activity in Heavily Pretreated Waldenström Macroglobulinemia - Targeted Oncology
~3y
Elranatamab Produces Efficacy Response in Penta-or Triple-Class Refractory Multiple Myeloma - Cancer Network
~3y
Intensive Remission Induction Chemotherapy Prior to alloHCT Does Not Show Survival Advantage in R/R AML - Targeted Oncology
~3y
Neoadjuvant Cemiplimab/REGN3767 Plus Paclitaxel Improves pCR in Early-stage, High-risk HER2– Breast Cancer - OncLive
~3y
Significant Gaps Still Remain in The Treatment of Breast Cancer - www.oncnursingnews.com/
~3y
BRCA Mutations, HRD Status Drive PARP Inhibitor Selection in Ovarian Cancer Maintenance - OncLive
~3y
Targeted Therapies and Expanded NGS Access Improve Decision Making in Lung Cancer - OncLive
~3y
Fellows' Passion Keeps Deol Sharp and Up to Date - OncLive
>3y